You just read:

MabVax Therapeutics Holdings, Inc. Announces the Closing of $1.3 Million Registered Direct Offering and is Engaging an Advisory Bank to Explore Strategic Alternatives

News provided by

MabVax Therapeutics Holdings, Inc.

Aug 22, 2017, 16:05 ET